Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor

By Han Dan-Dan   Wang Yun   Zhang Xin-Hua   Liu Jin-Rong   Wang Huai-Liang  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 4, 2012-04 ,pp. : 445-454

NRC Research Press

Access to resources Recommend Favorite

The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin

By Rakotoniaina Zo   Guerard Pascal   Lirussi Frederic   Goirand Françoise   Rochette Luc   Dumas Monique   Bardou Marc  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 3, 2006-12 ,pp. : 195-206

Springer Publishing Company

Access to resources Recommend Favorite

Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells

By Ou Hsiu-Chung   Chou Fen-Pi   Sheu Wayne   Hsu Shih-Lan   Lee Wen-Jane  

Archives of Toxicology, Vol. 81, Iss. 6, 2007-06 ,pp. : 421-432

Springer Publishing Company

Access to resources Recommend Favorite

The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

By Guerard Pascal   Rakotoniaina Zo   Goirand Françoise   Rochette Luc   Dumas Monique   Lirussi Frederic   Bardou Marc  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 6, 2006-09 ,pp. : 401-414

Springer Publishing Company

Access to resources Recommend Favorite

Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem

By Takahashi T.   Kanda T.   Imai S.   Suzuki T.   Kobayashi I.   Murata K.  

European Journal of Pharmacology, Vol. 295, Iss. 2, 1996-01 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite